Growth in adtech stocks, SPACs, and private equity has fueled interest in adtech deals this year. Business Insider asked a handful of investors, consultants and…Read More 8 companies that experts say could be acquired as digital advertising firms grow hot again
A report by UBS analyzed price growth in 25 major urban housing markets around the world from the second quarter of 2019 through the second…Read More The 7 cities around the world most at risk of a housing bubble
Prescription savings website GoodRx just acquired telemedicine startup HeyDoctor and plans to use the service to connect those scanning its website with doctors who can…Read More Pharmacy startups are getting into the business of prescribing medications — and it shows how a new business model is taking over in healthcare
A data-manipulation scandal has rocked Swiss drug giant Novartis and its new rare-disease treatment Zolgensma. A clearer picture is now emerging with a new59-page letter…Read More A major data-manipulation scandal has rocked Novartis. Here's everything we learned from a new 59-page letter the Swiss drug giant sent to its regulators.
The CEO ofHeadset, a data-analytics provider for the cannabis industry, revealed his key advice for making a successful pitch to potential investors. Cy Scott walked…Read More The CEO of cannabis-tech startup Headset told us why having a concise mission statement is crucial to successfully pitching investors
This story requires our BI Prime membership. To read the full article, simply click here to claim your deal and get access to all exclusive…Read More Pioneering genetic-testing company Myriad's biggest new product is facing pushback from US regulators that could 'significantly limit' the test's appeal. The stock is down 40%.
Genealogy giantAncestry is planning to get into health in a big way, according to the company’s CEO and a review of job postings. The company…Read More Ancestry’s DNA test has traced the family histories of more than 15 million people. Now, the genealogy giant plans to get into healthcare.
A new startup led by a veteran of Google’s Verily and the Swiss drug giant Roche is tackling women’s health issues like urinary tract infections.…Read More A startup led by a former Google exec and a pioneering scientist just raised $2.8 million to tackle a little-understood condition that affects 10 million people
Business Insider has selected the 30 leaders under 40 who are working to transform US healthcare. The list includes scientists, doctors, and entrepreneurs fighting to…Read More Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry
CVS Health operates 10,000 pharmacies, where you can buy soda and candy, and also pick up a prescription. The company recently acquired the health insurer…Read More CVS wants to change where millions of Americans go when they get sick. Here’s how it plans to get them in the door in the first place.
Flare Capital Partners raised $255 million in its latest fund and cofounder Michael Greeley told us what he wants to invest in next. Greeley said…Read More Flare Capital just raised $255 million, and the buzzy VC firm's cofounder told us he wants to invest in companies trying to reinvent the way we get healthcare in the US
This story requires our BI Prime membership. To read the full article, simply click here to claim your deal and get access to all exclusive…Read More Swiss drug giant Novartis has done $60 billion in deals over the past 18 months. One sentence from its CEO reveals the core strategy.
French drugmakerSanofi recently appointed Chief Medical OfficerAmeet Nathwani as its chief digital officer. The pharma industry is increasingly hiring chief digital officers as it seeks…Read More Using apps to treat diseases could be the future of healthcare. The first chief digital officer at pharma giant Sanofi told us his strategy for navigating the promises and pitfalls.
David Schenkein and Krishna Yeshwant, who lead the life sciences team atGV, formerly Google Ventures, want to upend the costly, time-consuming process of making new…Read More 2 top leaders at Google's $4.5 billion venture arm want to transform how new drugs get made to boost their entire portfolio
Healthcare investor and author Lisa Suennenreleased a list of “13 rules for healthcare entrepreneurs and investors.” The list was created in response to Mark Cuban’s…Read More A longtime healthcare VC just posted her 13 rules for entrepreneurs and investors, and they’re required reading for any startup that wants to get into the industry
If Vivek Garipalli, CEO and founder ofClover Health, could do it over again, he’s not sure he’d get into the health insurance business. “If I…Read More Clover Health set out to upend healthcare for aging Americans. 5 years and $925 million in funding later, it's proving more challenging than expected.
AbbVie’srecent deal for the pharmaceutical company Allergan is the latest in a string of healthcare mergers and acquisitions this year that have shifted the pharmaceutical…Read More 4 biotechs that could be the next takeout targets after AbbVie's $63 billion acquisition of Allergan
Genetic tests like one offered byMyriad Genetics claim to analyze a patient’s DNA and point them to the best depression drug for them. Myriad’s test…Read More Pioneering genetic-testing company Myriad's biggest up-and-coming product could be at risk after scientists raised major questions
Amazon acquired online pharmacyPillPack a year ago, signaling an entry by the powerful online retail giant into healthcare. We just got a peek at Amazon’s…Read More The first big clue about how Amazon plans to upend the US healthcare system with PillPack just dropped
Merck’s cancer drug Keytruda uses the body’s natural disease-fighting immune response to combat cancer. It has become apowerhouse for the company, bringing in $7 billion…Read More We spoke with a key Merck executive about the strategy for its top cancer drug, a $7 billion powerhouse that could soon bring in more than $20 billion
Amazon’s advertising business is growing, particularly in video advertising and measurement. But its ad business is spread across several teams, which can make it hard…Read More Marketers say that Amazon's advertising business is difficult to navigate. Here's why the company thinks the 'chaotic' structure actually makes sense.
Advertisers like Pringles, Cheez-It, Oscar Mayer, and Hertz continue to run ads on NTK Network, the “in-house fake news shop” run by Definers Public Affairs,…Read More Big advertisers like Kraft, Kellogg's, and Hertz are running ads on the shady site connected to Facebook's lobbying
UK-based pharma giant AstraZeneca has lost $12 billion in revenue in the past few years. That’s been in large part because of generic competition that’s…Read More We spoke to the president of AstraZeneca about the pharma giant’s plans to get back to growth after losing billions in sales to generic competition
The Atlantic Festival this week will be the publication’s largest stand-alone event with more than 15 underwriters and 2,500 attendees. AtlanticLive puts on more than…Read More The Atlantic thinks it’s found a winning formula for events by leaning on its weighty journalism, and the business is booming